Results

Total Results: 1,220 records

Showing results for "treatment".

381. Archived: Final Evidence Summary: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary11/carotid-artery-stenosis-screening-december-2007
     December 15, 2007 - search for RCTs, systematic reviews, and meta-analyses that compared carotid endarterectomy with medical therapy … angiographically confirmed CAS 60% or greater for random allocation to carotid endarterectomy or medical therapy … any perioperative stroke or death was lower in the carotid endarterectomy group than in the medical therapy … It is difficult to determine what effect current standard medical therapy would have on overall benefit … The use of current medical therapy could have reduced the stroke rate in the medical treatment arm of

382. N3Veybr4Zdhzfqsw3Erlhe (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
     November 01, 2014 - Studies comparing CEA or CAAS with current standard medical therapy are needed. … therapy alone and followed the patients for 2.7 to 9 years. … beyond current standard medical therapy. … and benefit beyond standard preventive treatments based on traditional cardio- vascular risk factors … of medical and surgical treatments, including the potential incremen- tal benefit of CEA.

383. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6cRgd5whkAvSGESSQsrQLR
     January 01, 2020 - Treatments and Interventions Asymptomatic adults at increased risk for CVD are usually treated with … Two RCTs (total N = 4626) compared using the ABI to guide decisions to start aspirin therapy vs usual … the effect of screening with CAC score on risk perception, adherence to medication, and behav- ioral therapies … Some comments also expressed belief that CAC score testing leads to better adherence to preven- tive therapies … It recommends judicious use of secondary test- ing among patients for whom the need for statin therapy

384. Screening for Syphilis Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Tse2TwVFQgYb-aNCq4Ngv
     September 04, 2018 - For evidence on the harms of treatment (KQ3), studies of penicillin treatment for syphilis in pregnant … the timing of screening, treatment, or both (eg, if screening, treatment, or both occurred earlier in … Harms of Treatment Key Question 3. … review was primarily focused on screening, it did not address the efficacy of alternative antibiotic treatments … Sexually transmitted diseases treatment guidelines, 2015.

385. Final Research Plan: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/carotid-artery-stenosis-screening
     November 14, 2019 - Does surgical repair provide incremental benefit beyond current medical treatment for asymptomatic persons … intima-media thickness for CVD risk prediction Comparisons KQs 1, 2: No screening KQ 3: Medical treatment … /usual care (e.g., statins, antiplatelet medications) KQ 4: Medical treatment/usual care or noncomparative

386. Archived: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening-2014
     March 18, 2014 - Treatment Pharmacologic treatments approved by the U.S. … Evidence shows that several drug therapies and nonpharmacologic interventions have a small effect on … allows clinicians to anticipate problems patients may have in understanding and adhering to recommended therapy … Pharmacologic treatments approved by the U.S. … Treatment of mild to moderate dementia with several drug therapies and nonpharmacologic interventions

387. Final Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medication-use-reduce-risk
     March 21, 2024 - Exclude Aim The use of medications to prevent primary breast cancer Use of medications for treatment … or prevention of other outcomes (e.g., breast cancer reoccurrence, treatment of osteoporosis) … prevention of primary breast cancer or unavailable in the United States Comparisons Placebo, no treatment

388. Final Research Plan: Pregnant Women: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-pregnant-women/human-immunodeficiency-virus-hiv-infection-screening
     June 15, 2017 - . †  Harms of treatment include adverse maternal and infant outcomes associated with use of antiretroviral … therapy. … treatment interruption Comparisons KQs 1, 3: HIV screening vs. no screening KQ 2: Repeat … the USPSTF revised the analytic framework to differentiate the harms of screening from the harms of treatment … diagnostic staging step, and clarify that the evidence review will focus on the benefits and harms of treatment

389. Zr66Ep5Abbqcuqy7Ktdetn (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZR66ep5ABbQCUQy7KTDETn
     July 01, 2014 - HBV treatment consists of antiviral regimens. … Approved first-line treatments are pegylated interferon- 2a, entecavir, and tenofovir. … Treatment Antiviral Regimens The goals of antiviral treatment are to achieve sus- tained suppression … Approved first-line treatments are pegylated interferon-�2a, enteca- vir, and tenofovir. … Combination therapies have been eval- uated but are not approved by the U.S.

390. Screening for Prostate Cancer: Clinical Summary (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/HUjbcP7uLa2SrGpVW4Fbhd
     for localized prostate cancer include watchful waiting, active surveillance, surgery, and radiation therapy … There is no consensus regarding optimal treatment. … discomfort of prostate biopsy and the psychological harm of false-positive test results. • Harms of treatment … years or older and for those whose life expectancy is 10 years or fewer, the incremental benefit from treatment

391. Screening for Colorectal Cancer: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DcUgaNRhU6PvJWXqqsa8X7
     Treatment and Interventions Treatment of early-stage colorectal cancer generally consists of local … Screening is most appropriate for those healthy enough to undergo treatment and those without comorbid

392. Archived: Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
     March 01, 2016 - for wet AMD (laser photocoagulation and photodynamic therapy). … Conclusions from the 2009 USPSTF review regarding the effectiveness of treatments vs no treatment … language studies has little effect on conclusions of reviews of noncomplementary and alternative therapies … . 62 In addition, trials of therapy for dry AMD evaluated heterogeneous vitamins, antioxidants, … Research is also needed to understand the effectiveness of new therapies that are being investigated

393. Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/36geybKjEXsHDoPkRR5KVZ
     June 01, 2008 - of dyslipidemia, and as- pirin therapy. … Several secondary pre- vention trials of treatments for people with lipid abnormal- ities reported that … reduce development and progression of albuminuria, it could not determine whether initiating these treatments … Treatments for diabetes are relatively safe. … Aspirin therapy in diabetes. Diabetes Care. 1997;20:1767-71. [PMID: 9353620] 29.

394. Final Research Plan: Nonpregnant Adolescents and Adults: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-nonpregnant-adolescents-and-adults/human-immunodeficiency-virus-hiv-infection-screening
     June 15, 2017 - . †  Harms of treatment include adverse effects associated with antiretroviral therapy, including cardiometabolic … studies KQ 5: Randomized, controlled trials and controlled observational studies; will consider treatment … diagnostic staging step, and clarify that the evidence review will focus on the benefits and harms of treatment … with antiretroviral therapy. … therapy regimens."

395. Kbjjfcap9Xvhkp43U-7B9Q (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KbJjfcaP9XvhkP43u-7b9q
     July 01, 2014 - Food and Drug Administration versus placebo or no treatment or first- line antiviral therapies (entecavir … Antiviral therapy versus placebo or no treatment for HBeAg loss. … Antiviral therapy versus placebo or no treatment for HBV DNA loss. … Antiviral therapy versus placebo or no treatment for HBsAg loss. … Antiviral therapy versus placebo or no treatment for incident cirrhosis.

396. Screening for Autism Spectrum Disorder in Young Children: Clinical Summary (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kQWchAnAnGxbQmpV9Gwo2H
     Treatment and Interventions Treatments for ASD include behavioral, medical, educational, speech/language … , and occupational therapy and complementary and alternative medicine approaches. … Treatments for young children are primarily behavioral interventions, particularly early intensive behavioral

397. Final Research Plan: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vision-in-children-ages-6-months-to-5-years-screening
     December 17, 2015 - For children with amblyopia, its risk factors, or refractive error, treatment may improve health outcomes … Treatment may also result in harms (key question 5). … Does treatment of amblyopia, its risk factors, and refractive error in children ages 6 months to 5 years … What are the harms of treatment of amblyopia, its risk factors, and refractive error in children ages … refractive error (eyeglasses); penalization of the nonamblyogenic eye (eye patch, atropine); and vision therapy

398. Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7eLc5kBtomL_HKpYDwsFPf
     July 01, 2009 - For ben- efits and harms of treatments, quantitative estimates for treatment effects from good-quality … For efficacy of treatments, we reported quantitative estimates for treatment effects from previously … Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. … Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. … Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group.

399. Final Evidence Review: Rh(D) Incompatibility: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review86/rh-d-incompatibility-screening
     February 15, 2004 - fetal anemia in pregnancies complicated by Rh (D) incompatibility. 2 , 3 Key Question 3: Have new treatment … We found no RCTs with direct evidence addressing new treatment protocols developed and tested to show … Key Questions 4 and 5: Have new harms been identified for screening or treatment of Rh (D) incompatibility … no RCTs with direct evidence identifying either new or stronger harms associated with screening or treatment

400. Archived: Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
     June 26, 2018 - Pharmacologic treatments for osteoporosis inhibit osteoclastic bone resorption (antiresorptive agents … Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … Benefits of Treatment Key Question 4a. … Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. … Fracture risk and zoledronic acid therapy in men with osteoporosis.